BridgeMD
Compares treatment options for Insomnia Chronic
Official title Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia
ClinicalTrials.gov ID: NCT06636006
What this study is testing
- What it's testing
- The purpose of this study is to compare the effects of aerobic exercise versus digital CBT-I in university students with insomnia complaints. This is a clinical trial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ages ≥ 18 years old
- insomnia severity index score \>8
- be physically inactive according to the IPAQ questionnaire
You likely can't join if
- non-adherence to intervention protocols
- absence or incomplete answers in the questionnaires/evaluation methods of the study
- shift workers
The study team makes the final eligibility decision.
Where it's taking place
- Jatai, Goiás, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jatai, Goiás, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.